Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Orbach

Showing results (291-300 of 351) with videos related to

Pageof 36
Sort By:
Pediatric Blood & Cancer|November 27, 2020
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groupsSoledad Gallego, Yueh-Yun Chi, Gian Luca De Salvo, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
Pediatric Radiology|August 14, 2025
Early radiologic tumour volume response in non-metastatic rhabdomyosarcoma is not predictive for survivalIsabelle S A de Vries, Carlo Morosi, Gianni Bisogno, et al.
Expert Review of Anticancer Therapy|July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysisLauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.
The Lancet. Oncology|June 27, 2018
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trialGianni Bisogno, Meriel Jenney, Christophe Bergeron, et al.
Cancer|May 28, 2025
Impact of maintenance treatment on male gonadal function in patients treated for localized rhabdomyosarcoma in RMS2005 trial in FranceLea Rossillon, Cécile Thomas-Teinturier, Daniel Orbach, et al.
Cancer|November 22, 2019
Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experienceBas Vaarwerk, Coralie Mallebranche, Maria C Affinita, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2021
The Impact of Radiation Therapy in Children and Adolescents With Metastatic RhabdomyosarcomaAlison L Cameron, Markus C Elze, Michela Casanova, et al.
Frontiers in Pediatrics|February 21, 2022
Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French ExperienceRoxane Machavoine, Sylvie Helfre, Valérie Bernier, et al.
Head & Neck|November 15, 2024
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 StudyReineke A Schoot, Pieter Taselaar, Giovanni Scarzello, et al.
Pageof 36

Showing results (291-300 of 351) with videos related to

Sort By:
Pageof 36
Pediatric Blood & Cancer|November 27, 2020
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groupsSoledad Gallego, Yueh-Yun Chi, Gian Luca De Salvo, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
Pediatric Radiology|August 14, 2025
Early radiologic tumour volume response in non-metastatic rhabdomyosarcoma is not predictive for survivalIsabelle S A de Vries, Carlo Morosi, Gianni Bisogno, et al.
Expert Review of Anticancer Therapy|July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysisLauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.
The Lancet. Oncology|June 27, 2018
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trialGianni Bisogno, Meriel Jenney, Christophe Bergeron, et al.
Cancer|May 28, 2025
Impact of maintenance treatment on male gonadal function in patients treated for localized rhabdomyosarcoma in RMS2005 trial in FranceLea Rossillon, Cécile Thomas-Teinturier, Daniel Orbach, et al.
Cancer|November 22, 2019
Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experienceBas Vaarwerk, Coralie Mallebranche, Maria C Affinita, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2021
The Impact of Radiation Therapy in Children and Adolescents With Metastatic RhabdomyosarcomaAlison L Cameron, Markus C Elze, Michela Casanova, et al.
Frontiers in Pediatrics|February 21, 2022
Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French ExperienceRoxane Machavoine, Sylvie Helfre, Valérie Bernier, et al.
Head & Neck|November 15, 2024
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 StudyReineke A Schoot, Pieter Taselaar, Giovanni Scarzello, et al.
Pageof 36